Feature | August 23, 2010

European Distribution Agreement for Radiation Therapy System Signed

August 23, 2010 - Calypso Medical Technologies Inc., entered into a distribution agreement with Siemens Healthcare for the sale of its Calypso System in Europe.

The Calypso System is a real-time localization technology used for the precise tracking of tumor targets.

“This agreement extends the availability of our GPS for the Body technology into geographic areas with significant incidences of prostate cancer," said Jed Palmacci, vice president of global sales for Calypso Medical.

Under terms of the agreement, Siemens retains nonexclusive rights to sell Calypso’s real-time tracking technology to existing and prospective Siemens linear accelerator customers throughout Europe for a period of three years.

Last year Calypso Medical entered into a master development agreement (MDA) with Siemens to jointly develop products integrating the Calypso System with the Siemens ARTISTE linear accelerator and other Siemens radiotherapy technologies.

With recent clinical findings of improved outcomes, Calypso's GPS for the Body technology enables doctors to localize and track the tumor before and during each radiation treatment. When the tumor moves outside of the field of radiation, therapy can be stopped while the patient is repositioned to ensure that the tumor, not surrounding healthy tissue, receives the radiation dose.

In contrast to other tumor targeting solutions, the Calypso System provides continuous tumor position information, objectively and without ionizing radiation, thereby safeguarding the patient from an additional nontherapeutic radiation dose.

For more information: www.calypsomedical.com, www.siemens.com/healthcare

Related Content

Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
Mercy Signs Multi-System, Multi-Hospital Agreement for Accuray Radiotherapy Systems
News | Radiation Therapy | May 16, 2018
Accuray Inc. signed a multi-system, multi-hospital agreement with Mercy for the acquisition of Accuray Radixact and...
Overlay Init